(PharmaNewsWire.Com, November 29, 2017 ) The World Halitosis Treatment Market is expected to reach USD 22,153.4 billion by 2023, and the market is projected to grow at a healthy CAGR of 18.58% during the forecast period 2017-2023.
The Global Halitosis Treatment Market is segmented into pathological halitosis and others. Pathological halitosis is divided into oral pathological halitosis and extra oral pathological halitosis. Other types include physiological halitosis. The most common cause of halitosis is lack of oral hygiene and lack of awareness about diagnosis of this disease. Halitosis treatment market is expected to show a massive growth due to availability of a wide range of dental health care products, increasing geriatric population and rising prevalence of periodontal diseases.
The Major Key players of Global Halitosis Treatment Market:
Rowpar Pharmaceuticals, Inc. (U.S),
Abbott (U.S),
Listerine (U.S),
AstraZeneca (U.S).
Colgate-Palmolive Company (U.S),
All USA Partners LLC (U.S),
Dr. Harold Katz, LLC (U.S),
The Worldwide Halitosis Treatment Market is segmented into four main regions namely America, Europe, Asia Pacific and Middle East & Africa. Halitosis is a clinical condition characterized by unpleasant odor present in the mouth due to various periodontal and chronic diseases. It has become a social problem affecting large number of people across the world.
Regional Analysis:
In the Middle East & Africa, the market is expected to witness a moderate growth owing to poor economic conditions, and lack of awareness about oral health.
The Americas account for a significant market share owing to rising prevalence of gum diseases and extensive use of oral care products such as toothpastes, mouth washes, mouth sprays, etc. In 2013, in the US, USD 810 million was spent for halitosis treatment.
Europe is the second largest market in the world whose growth is attributed to an increase in awareness regarding halitosis and products available for its treatment. Furthermore, increasing demand for new oral care products influence the market growth.
Asia Pacific region is expected to grow rapidly due to rising prevalence of chronic diseases such diabetes, respiratory diseases, kidney or liver failure with the increasing population. Rising geriatric population suffering from these diseases also contribute to the market growth.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
